Aurinia Pharmaceuticals (AUPH) Intangibles (2016 - 2026)
Aurinia Pharmaceuticals' (AUPH) quarterly Intangibles came in at $3.6 million in Q1 2026, down 13.66% YoY from $4.2 million in Q1 2025, and down 4.55% on a QoQ basis from $3.8 million in Q4 2025.
Aurinia Pharmaceuticals (AUPH) Intangibles (2016 - 2026) Analysis & Trends
Aurinia Pharmaceuticals (AUPH) has 11 years of Intangibles data on file, last reported at $3.6 million in Q1 2026.
- Quarterly Intangibles fell 13.66% year-over-year to $3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.6 million (down 13.66% YoY) and the FY2025 annual result came in at $3.8 million, down 13.64% from the prior year.
- Intangibles eased to $3.6 million in Q1 2026, from $3.8 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $7.9 million in Q1 2022 to a low of $3.6 million in Q1 2026.
- A 5-year average of $5.2 million and a median of $4.8 million in 2024 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2022 — Intangibles fell 23.55% — and 2025, when it fell 12.44%.
- Tracing AUPH's Intangibles over 5 years: stood at $6.4 million in 2022, then retreated by 22.54% to $5.0 million in 2023, then retreated by 12.5% to $4.4 million in 2024, then retreated by 13.64% to $3.8 million in 2025, then decreased by 4.55% to $3.6 million in 2026.
- The last three Intangibles figures came in at $3.6 million (Q1 2026), $3.8 million (Q4 2025), and $3.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 266.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 63.28 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 60.96 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 93.49 Mn |
| 10 | Aurinia Pharmaceuticals | 2.06 Bn | 1.61 Bn | 76.67 Mn | 3.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.38 Mn |
| Mar 31, 2026 | 3.59 Mn |
| Dec 31, 2025 | 3.76 Mn |
| Sep 30, 2025 | 3.90 Mn |
| Jun 30, 2025 | 4.05 Mn |
| Mar 31, 2025 | 4.16 Mn |
| Dec 31, 2024 | 4.36 Mn |
| Sep 30, 2024 | 4.51 Mn |
| Jun 30, 2024 | 4.62 Mn |
| Mar 31, 2024 | 4.76 Mn |
| Dec 31, 2023 | 4.98 Mn |
| Sep 30, 2023 | 5.26 Mn |
| Jun 30, 2023 | 5.68 Mn |
| Mar 31, 2023 | 6.10 Mn |
| Dec 31, 2022 | 6.43 Mn |
| Sep 30, 2022 | 6.84 Mn |
| Jun 30, 2022 | 7.34 Mn |
| Mar 31, 2022 | 7.88 Mn |
| Dec 31, 2021 | 8.40 Mn |
| Sep 30, 2021 | 8.93 Mn |